However, besides inflammation, several studies implicate a role of TNFα signalling during tumour development and also infectious diseases, therefore anti-TNFα treatment might be a starting point for additional therapeutic strategies to cure intestinal diseases. This evidence concerns the gene TNF and intestinal disorder.